Clinical Trial Update: Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiotherapy in combination with sintilimab, GM-CSF, and fruquintinib in patients with metastatic microsatellite-stable colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Neoplasms

Drugs mentioned

• Fruquintinib (fruquintinib)
• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Sintilimab (sintilimab)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Colorectal Neoplasms | Phase 2 | Status: UNKNOWN